Clinical Trial Update: Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid Synthesis [Phase 3]

View source ↗

Summary

Phase 3 trial update of TBM cholic acid capsules for children with inborn errors of bile acid synthesis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inborn Errors of Bile Acid Synthesis

Drugs mentioned

• To Be Marketed (TBM) cholic acid capsules (cholic acid)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Inborn Errors of Bile Acid Synthesis | Phase 3 | Status: COMPLETED | Results posted: 2016-12-09